Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

Not really. Short-term (a few days) impact of

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Dan88 Member Profile
 
Followed By 49
Posts 1,385
Boards Moderated 0
Alias Born 08/12/14
160x600 placeholder
Northwest Biotherapeutics secures $15M financing on stock purchase rights Seeking Alpha - 11/29/2021 11:11:27 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/15/2021 4:41:30 PM
IQST Has Catalysts On Deck That Expose A Valuation Disconnect of Roughly 100% - Here's Why That Gap Should Close InvestorsHub NewsWire - 11/5/2021 10:20:59 AM
iQSTEL, Inc. - The Calm Before The Surge (OTCQX: IQST) InvestorsHub NewsWire - 10/29/2021 2:31:48 PM
Star Alliance Intl. Corp. (OTC Pink: STAL) Recent Gold Mine Acquisition NI43-101 InvestorsHub NewsWire - 10/29/2021 7:08:34 AM
IQST - EV & Hi-Tech Company Poised For Potential 4X ROI - Q3 Financials and Short Squeeze InvestorsHub NewsWire - 10/14/2021 11:34:44 AM
CEO Presenting on the Emerging Growth Conference on October 13 Register Now InvestorsHub NewsWire - 10/11/2021 7:00:00 AM
CLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% Growth InvestorsHub NewsWire - 9/28/2021 7:24:31 AM
CEO Presenting on the Emerging Growth Conference on September 29  Register Now InvestorsHub NewsWire - 9/27/2021 8:35:40 AM
CEO Presenting on the Emerging Growth Conference Tomorrow.  Register Now InvestorsHub NewsWire - 9/14/2021 7:00:00 AM
CEO Presenting on the Emerging Growth Conference on September 15.  Register Now InvestorsHub NewsWire - 9/13/2021 7:00:00 AM
CEO Presenting on the Emerging Growth Conference on September 1.  Register Now InvestorsHub NewsWire - 8/31/2021 7:00:00 AM
CLS Holdings, (OTCQB: CLSH) July Sales $1.9 Million 104% increase over July 2019 InvestorsHub NewsWire - 8/17/2021 7:21:24 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2021 4:41:47 PM
CEO Presenting on the Emerging Growth Conference on August 4.  Register Now InvestorsHub NewsWire - 8/3/2021 7:00:00 AM
WSGF - World Series of Golf Inc VERY BULLISH Signal Continues InvestorsHub NewsWire - 8/2/2021 9:45:22 AM
CEO Presenting on the First Emerging Growth / Investors Hub Joint Conference on July 21 InvestorsHub NewsWire - 7/19/2021 7:00:00 AM
CEO Presenting on the Emerging Growth / Investors Hub Joint Conference Tomorrow.  Register Now InvestorsHub NewsWire - 7/6/2021 7:00:00 AM
Sino United (OTC Pink: SUIC) $200 Million Commitment, Signs with Suntech, the Largest Taiwan O2O Company. InvestorsHub NewsWire - 6/30/2021 7:30:00 AM
CEO Presenting on the First Emerging Growth / Investors Hub Joint Conference Tomorrow!  Register Now InvestorsHub NewsWire - 6/22/2021 7:00:00 AM
CEO's Presenting at Emerging Growth Conference Virtually This Week InvestorsHub NewsWire - 6/7/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/24/2021 4:35:22 PM
Northwest Bio gaining attention as investors await phase 3 GBM data Seeking Alpha - 5/24/2021 11:16:44 AM
CEO's Presenting at Emerging Growth Conference Virtually This Week InvestorsHub NewsWire - 5/24/2021 7:03:10 AM
IQST Signals BUY InvestorsHub NewsWire - 5/20/2021 9:43:19 AM
Dan88   Tuesday, 06/29/21 09:53:40 AM
Re: trocprofit post# 386924
Post # of 423547 
Not really. Short-term (a few days) impact of the failure of cvm on nwbo price - everybody has seen it now

med-term (within week) impact -- favorable for nwbo price appreciation

Long-term impact - none

only explain the first one - sympathy price drop understandable as most investors particularly non-investors who are considering and about to take a position are ignorant and have not done their DD yet. after some digging and digesting, actually those undecided or those who may be panic and sold some shares will finally realize

1) Multikine and DCVax-L are actually two different beasts

2) NWBio will be most likely meeting its primary and key secondary endpoints

3) the worst scenario for nwbo price drop if ever it would fail in its trial not meeting its primary endpoint like CVM is in the worst case 40%, not really that much expected by most investors

As a matter of fact, NWBio will probably meet its primary and key secondary endpoints

[conclusion:} new blood will flow into nwbo within days]

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences